Double-blind placebo controlled olanzapine add-on therapy in the treatment of acute syndromal and subsyndromal exacerbations in bipolar disorders

Trial Profile

Double-blind placebo controlled olanzapine add-on therapy in the treatment of acute syndromal and subsyndromal exacerbations in bipolar disorders

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2017

At a glance

  • Drugs Olanzapine (Primary)
  • Indications Bipolar depression; Bipolar disorders; Bipolar II disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Jul 2012 Results published in the Journal of Psychiatric Research.
    • 14 Oct 2010 Planned end date added to 1 Dec 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top